List of insiders holdings for REVA Medical Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Senrigan Capital Management Ltd Senrigan Capital Group Ltd Taylor Nicholas 10% Owner | 2019-02-14 06:09:54 | 0 12,453,969 | 12,453,969 | Form 5 |
| DOMAIN PARTNERS V LP 10% Owner | 2013-01-16 15:59:00 | 3,606,002 0 | 3,606,002 | Form 13G |
| FERRANTE DOMENIC J BROOKSIDE CAPITAL MANAGEMENT LLC Brookside Capital Trading Fund L.P. Brookside Capital Investors II L.P. 10% Owner | 2019-02-14 09:07:11 | 2,965,022 0 | 2,965,022 | Form 13G |
| SAINTS CAPITAL EVEREST LP 10% Owner | 2017-05-11 14:16:02 | 2,901,171 0 | 2,901,171 | Form 13G |
| FEINBERG STEPHEN Former 10% Owner | 2011-02-14 19:10:22 | 2,884,426 0 | 2,884,426 | Form 13G |
| FERRANTE DOMENIC J BROOKSIDE CAPITAL PARTNERS FUND LP BROOKSIDE CAPITAL INVESTORS L P BROOKSIDE CAPITAL MANAGEMENT LLC 10% Owner | 2015-02-17 13:42:19 | 2,783,204 0 | 2,783,204 | Form 13G |
| GOLDMAN SACHS GROUP INC GOLDMAN SACHS INTERNATIONAL 10% Owner | 2019-04-04 17:27:11 | 1,930,305 0 | 1,930,305 | Form 13G |
| Nye Gordon E Director | 2016-07-25 19:27:06 | 877,785 0 | 877,785 | Form 4 |
| Stockman Robert Bernard Director | 2019-11-14 15:50:20 | 703,477 0 | 703,477 | Form 4 |
| LARKIN C RAYMOND JR Director | 2018-07-02 20:00:24 | 371,381 0 | 371,381 | Form 4 |
| Schultz Robert K. President & COO | 2017-05-19 18:27:42 | 277,000 5000 | 282,000 | Form 4 |
| GROVES REGINA E Chief Executive Officer | 2018-07-02 19:40:19 | 245,924 0 | 245,924 | Form 4 |
| Thompson Katrina CFO & Secretary | 2017-03-22 17:51:37 | 213,975 0 | 213,975 | Form 4 |
| Thomas Robert Bain Director | 2018-07-02 20:10:19 | 53,660 100,000 | 153,660 | Form 4 |
| Anderson Jeffrey A. SVP, Clinical & Regulatory | 2018-01-23 21:10:19 | 116,000 0 | 116,000 | Form 4 |
| DP V ASSOCIATES LP 10% Owner | 2012-03-27 15:15:09 | 85,186 0 | 85,186 | Form 4 |
| BLAIR JAMES C 10% Owner | 2012-03-27 15:23:55 | 0 85,186 | 85,186 | Form 4 |
| TREU JESSE I 10% Owner | 2012-03-27 15:34:10 | 0 85,186 | 85,186 | Form 4 |
| SCHOEMAKER KATHLEEN K 10% Owner | 2012-03-27 15:41:10 | 0 85,186 | 85,186 | Form 4 |
| Elkolli Leigh Chief Financial Officer | 2019-01-14 21:07:54 | 70,000 0 | 70,000 | Form 3 |
| KIMES RICHARD M. Senior VP, Operations | 2018-07-02 19:50:22 | 57,152 0 | 57,152 | Form 4 |
| Roberts Brandi SVP & Chief Financial Officer | 2018-07-02 19:45:20 | 54,908 0 | 54,908 | Form 4 |
| Keating Anne Director | 2016-07-25 19:32:02 | 33,100 18,606 | 51,706 | Form 4 |
| Oesterle Stephen N. Director | 2018-07-02 20:05:19 | 49,360 0 | 49,360 | Form 4 |
| Huennekens R Scott Director | 2017-07-11 20:15:41 | 37,800 0 | 37,800 | Form 4 |
| Breckenridge Ross Director | 2018-05-18 20:55:17 | 25,000 0 | 25,000 | Form 4 |
| SCHIRO JAMES J Director | 2014-05-14 17:36:56 | 15,000 0 | 15,000 | Form 4 |
| Brandom Donald K. SVP, Product Development | 2016-08-11 19:32:02 | 12,250 0 | 12,250 | Form 4 |
| Zeltinger Joan K. VP, Scientific Affairs | 2016-03-01 12:33:39 | 6750 0 | 6750 | Form 4 |
| Schmid Eric V. VP of Advanced Technology | 2011-10-14 17:44:59 | 5000 0 | 5000 | Form 4 |
| DOVEY BRIAN H Director | 2019-11-13 16:48:58 | 0 0 | 0 | Form 4 |